XML 198 R49.htm IDEA: XBRL DOCUMENT v3.25.0.1
Loss Per Share (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2024
Dec. 31, 2023
Earnings Per Share [Abstract]    
Schedule of Loss Per Share

The computation of loss per share is as follows:

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

(in thousands, except share and per share amounts)

 

(in thousands, except share and per share amounts)

 

 

(in thousands, except share and per share amounts)

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(7,141

)

 

$

(10,408

)

 

$

(29,172

)

 

$

(39,971

)

Net loss attributable to common stockholders

 

$

(7,141

)

 

$

(10,408

)

 

$

(29,172

)

 

$

(39,971

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average common stock outstanding -
   basic and diluted

 

 

46,535

 

 

 

3,547

 

 

 

19,164

 

 

 

2,938

 

Net loss per share attributable to common
   stockholders - basic and diluted

 

$

(153.46

)

 

$

(2,934.67

)

 

$

(1,522.25

)

 

$

(13,606.08

)

 

The computation of loss per share is as follows:

 

 

Year ended December 31,

 

 

2023

 

 

2022

 

(in thousands, except share and per share amounts)

 

(in thousands,
except share and per share amounts)

 

Numerator:

 

 

 

 

 

 

Net loss

 

$

(51,373

)

 

$

(58,225

)

Net loss attributable to common
   stockholders

 

$

(51,373

)

 

$

(58,225

)

Denominator:

 

 

 

 

 

 

Weighted average common stock
   outstanding - basic and diluted

 

 

3,092

 

 

 

122

 

Net loss per share attributable to common
   stockholders - basic and diluted

 

$

(16,614.85

)

 

$

(477,963.21

)

Schedule of Potentially Dilutive Shares

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:

 

 

September 30,

 

 

 

2024

 

 

2023

 

 

Warrants to purchase common stock

 

 

61,342

 

 

 

 

 

Series A Preferred Stock conversion to common stock

 

 

76,154

 

 

 

 

 

Series B Preferred Stock conversion to common stock

 

 

914

 

 

 

 

 

Series C Preferred Stock conversion to common stock

 

 

57,223

 

 

 

 

 

Stock options to purchase common stock

 

 

809

 

 

 

777

 

 

Total

 

 

196,442

 

 

 

777

 

 

The following potentially dilutive shares were not included in the calculation of diluted shares outstanding as the effect would have been anti-dilutive:

 

 

December 31,

 

 

2023

 

 

2022

 

Series Seed 10 convertible preferred stock
   (as converted to common stock)

 

 

 

 

 

23

 

Warrants to purchase series Class B common
   stock (as converted to common stock)

 

 

 

 

 

1

 

Warrants to purchase common stock issued with December 2023 Note

 

 

231

 

 

 

 

Stock options to purchase common stock

 

 

855

 

 

 

112

 

Total

 

 

1,086

 

 

 

136